Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Dedifferentiated Liposarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00969917
What this trial is testing

Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Infinity Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT04242238
What this trial is testing

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Who this might be right for
SarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT06975293
What this trial is testing

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Who this might be right for
Solid TumorSarcomaLeiomyosarcoma+1 more
STORM Therapeutics LTD 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114527
What this trial is testing

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Who this might be right for
Soft Tissue Sarcoma
Fox Chase Cancer Center 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871
What this trial is testing

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more
Alliance for Clinical Trials in Oncology 77
Testing effectiveness (Phase 2)Ended earlyNCT05580588
What this trial is testing

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Who this might be right for
Liposarcoma, Dedifferentiated
Shanghai Pharma Biotherapeutics USA Inc. 14
Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06389799
What this trial is testing

A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

Who this might be right for
Dedifferentiated Liposarcoma
Lund University Hospital 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04438824
What this trial is testing

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Who this might be right for
Well-differentiated/Dedifferentiated Liposarcoma
Memorial Sloan Kettering Cancer Center 42
Large-scale testing (Phase 3)Active Not RecruitingNCT04967521
What this trial is testing

SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated Liposarcoma
Sarcoma Alliance for Research through Collaboration 108
Early research (Phase 1)Looking for participantsNCT05711615
What this trial is testing

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Who this might be right for
Metastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more
National Cancer Institute (NCI) 30